Hi ALL,

Lock down here in Perth is progressing well - No community transmission at this stage.

However - this pandemic, is ongoing for the rest of the world, as we are all aware.

With data due from LUMC, imminently, we will all know for sure where PharmAust stands.

Will MPL or MPLS, be the live saving treatment, that is what we are all hoping for?

Judging, by the past results - it may very well be and exceed expectations?

Iv'e spoken to PharmAust over the last couple of weeks.
Today I had confirmation that there will be a Q&A session in the next week or two. "It will be similar to what we did at the AGM which was received well. We’ll make an announcement calling for questions like we did last time."
In the ten years that I've held this stock, Iv'e always felt confident and comfortable with my investment, but even more so now. Management are upbeat, excited and PharmAust is progressing - probably a lot more, than what we understand at this particular moment.

Here is an article that follows on from yesterday - that is by coincidence - backing up yesterdays news - that the pandemic will be ongoing.

Fears new coronavirus strain has 'developed a superpower'

Tom Flanagan

·News Reporter

Updated Wed, 3 February 2021, 7:14 am·3-min read

The highly-infectious UK coronavirus strain has made another “troublesome” mutation which could lead to the virus evading immunisation.

Public Health England confirmed genomic testing has found infections with the E484K mutation seen in the highly transmissible South African and Brazilian variants.

Former Harvard epidemiologist Dr Eric Feigl-Ding explained various antibodies are 10 times less effective when faced with the mutation in some patients, which he described as “a rather bad thing”.

“It means the virus with E484K is worrying for “immune escape”,” he said on Twitter.

Recent research regarding the variant by the National Institute For Communicable Diseases of South Africa revealed 48 per cent of people previously positive with Covid-19 had “complete immune escape”.

Dr Feigl-Ding said it has potential to become a "super strain”,while
Sky’s science correspondent said the strain had “developed a superpower”.

Public Health England said there were 11 cases detected, and Dr Feigl-Ding said evidence suggested they were acquired independently, meaning the virus was evolving separately.

And while early research suggests the mutation is more resistant to antibodies, vaccine developers including Moderna and Pfizer believe their vaccines will work despite a slight drop in effectiveness.

The UK continues to record more than 20,000 cases a day. Source: AP

Health minister Matt Hancock said it was too early to tell the impact of variants on vaccines, but mutations of concern had been reported in Bristol and Liverpool.

"We must continue to act with caution, not least because of the renewed challenges posed by new variants of the coronavirus," he told lawmakers.

UK starts door-to-door testing

Calum Semple, who is part of a panel that advises the British government, told BBC radio that E484K was the "mutation of most concern", and had "occurred spontaneously" in the UK variant.

Public Health England said it was “monitoring the situation closely”.

“All necessary public health interventions are being undertaken, including enhanced contact tracing and control measures,” a spokesperson said.

Authorities in the UK, which is currently under a nationwide lockdown, have begun door-to-door mobile testing in a bid to get the full picture on the mutation’s prevalence.

• Daunting warning as virus tend hits ‘concerning’ six-week low

• ‘Never ending’: Expert’s shocking coronavirus prediction

• Confronting photos emerge as thousands flout Covid rules

“In all these areas [where the mutation has been detected] it is imperative that people must stay at home and only leave home where it is absolutely essential,” Mr Hancock said.

The UK has now vaccinated 9.2 million people, about 14 per cent of its population.

There has been 3,863,755 cases in the UK since the pandemic began while there has been 108,225 deaths.

While daily infections have dropped during the third wave’s lockdown, 24-hour case totals remain above 20,000.

The question is, just how many strains will MPL or MPLS treat? If PharmAust is fortunate, and MPL or MPLS treats all strains of CV-19 or SARS virus, one gets the feeling, that just about no matter how fast it is produced, it will run out the doors of pharmacies, like there is no tomorrow.


The benefits of an OTC medicines are enormous. In the case of MPL, it would lead to
hospital beds being freed up, and in particular easing pressure on the medical system.
Economies back to work and most importantly, lives saved along with normality as we all know it.


Be patient and we will all be rewarded - as difficult as it may be.

As Always
Best
Mickey Mouse